Australia Diabetes Market, By CGM, SMBG, Insulin Pen & Pump, Companies - PowerPoint PPT Presentation

About This Presentation

Australia Diabetes Market, By CGM, SMBG, Insulin Pen & Pump, Companies


Australia Diabetes Market is expected to reach USD 2.44 Billion by the year 2025. By Continuous Glucose Monitoring, Self Monitoring Blood Glucose Device, Insulin Pen & Pump, Forecast & Company Analysis – PowerPoint PPT presentation

Number of Views:62
Slides: 11
Provided by: PrateekRenub
Category: Other


Transcript and Presenter's Notes

Title: Australia Diabetes Market, By CGM, SMBG, Insulin Pen & Pump, Companies

Australia Diabetes Market
Australia Diabetes Market
Report Description and Highlights
Australia ranked seventh in the world for the
prevalence of type 1 diabetes in children and 6th
highest for incidence. There is also rising
prevalence of particularly type 2 diabetes and
rising cases of children and adolescents who are
now impated by type 2 diabetes in Australia.
Type 1 diabetes typically happens in an early
age, its a most common form of childhood diabetes
although it can occur at any age. Over 1 million
Australians have been diagnosed with diabetes.
Australia is dragging behind many western
countries in providing affordable access to its
people with diabetes to new, proven technologies
such as CGM and Insulin pen that can
significantly improve the management of diabetes.
Australia Diabetes Market is expected to
reach USD 2.44 Billion by the year 2025.
Australia Diabetes Market
Australia Diabetes Market
The market of Self Monitoring Blood Glucose
Device, Continuous Glucose Monitoring (CGM)
Device, Insulin Pump, and Insulin Pen are growing
due to the rising awareness for diabetes in
Australia. Diabetes care in Australia has reached
a high level of quality, but there is still an
opportunity for further improvement. Diabetes is
associated with an uncountable of complications
that affect the eyes, feet, kidneys, and
cardiovascular health. Besides, diabetes is
ranked in the top 10 leading causes of deaths in
Australia. Diabetes is a massive challenge to the
nations health and economy. Australian
Government has essential roles in maintaining
access to affordable, high-quality devices and
services to support people with diabetes in
self-management and treatment. The Australian
Government providing support to people with
diabetes through the National Diabetes Services
Scheme, the Pharmaceutical Benefits Scheme, the
Insulin Pump Program, and Medicare. In 2019,
Biocon and Mylan N V launched insulin glargine
biosimilar Semglee, first insulin PBS in
Australia. In 2019, TAL, a leading Australian
life insurance specialist, has launched a
specialized product to protect people with
diabetes mellitus in Australia.
Australia Diabetes Market
Australia Diabetes Market
Renub Research report titled Australia Diabetes
Market Forecast, By Self Monitoring Blood
Glucose Device Analysis (SMBG Market by, Test
Strips, Lancet, Meter, Blood Glucose Device Users
Reimbursement), Continuous Glucose Monitoring
(CGM Market by Components, Glucose Sensor,
Transmitter, CGM User, Reimbursement), Insulin
Pump Analysis- (Users, Market Differentiation
Points of Insulin Pump Products, Training Model
for Patients HCP, Reimbursement Policies),
Insulin Pen Analysis (User, Types Disposable,
Reusable and Smart Insulin Pen, Insulin Pen
Needle Market, Reimbursement Policies), Companies
(Eli Lilly and Company, B. Braun Melsungen AG,
Ypsomed AG, Artsana S.p.A, BD, Novo Nordisk A/S,
Medtronic, Insulet Corporation, Owen Mumford Ltd,
LifeScan Inc., Dexcom Inc, Abbott Laboratories
and Roche) provides a complete analysis of
Australia Insulin Delivery Devices Market.
Request a free sample copy of the report
Australia Diabetes Market
Australia Diabetes Market
Forecast for Australia Diabetes Market Share ()
- Segments (2020 - 2025)
Source Renub Research Analysis Note
These are dummy figures actual data given in the
Australia Diabetes Market
Australia Diabetes Market
  • Segments Market based on Devices
  • 1.   Continuous Glucose Monitoring (CGM) 2.  
     Self Monitoring Blood Glucose (SMBG)
  • 3.    Insulin Pen 4.   Insulin Pump
  • Australia Diabetes Sub-Segment Analysis
  • Continuous Glucose Monitoring (CGM)
  • 1.    Glucose Sensor Market Forecast 2.    CGM
    Transmitter Market Forecast3.    CGM
    User 4.    CGM Reimbursement
  • 2. SMBG
  • 1.    Test Strips Market and Forecast 2.  
     Lancet Market and Forecast3.    Meter Market
    and Forecast 4.    Blood Glucose (SMBG)
    Users5.    Blood Glucose Devices Reimbursement

Australia Diabetes Market
Australia Diabetes Market
3. Insulin Pen Market 1.    Disposable Insulin
Pen 2.    Reusable Insulin Pen3.    Smart
Insulin Pen 4.    Insulin Pen Needle Market5.  
 Insulin Pen Users 6.    Reimbursement
Policies 4. Insulin Pump Market 1.    Insulin
Pump Market 2.    Insulin Pump Users3.  
 Insulin Pump Products 4.    Reimbursement
Policies All the 14 Companies Studied in the
Report have been Studied from 3 Points   
 Company Overview     Recent Developments  
 Financial Insigh
Request a free Brochure copy of the report
Australia Diabetes Market
Australia Diabetes Market
  • Company Analysis
  • 1.    B. Braun Melsungen AG 2.    Eli Lilly and
    Company 3.    Artsana S.p.A4.    BD 5.  
     Novo Nordisk A/S 6.    Owen Mumford Ltd7.  
     Ypsomed AG 8.    Medtronic 9.    Insulet
    Corporation10.    LifeScan Inc. 11.    Abbott
    Laboratories 12.    Roche13.    Dexcom Inc
  • Key Benefits of the Report
  • This report provides current market estimates and
    forecasts for Australia Diabetic Market.
  • Detailed analysis of the key market segments such
    as source, geography and applications provides a
    comprehensive understanding of the market.
  • Australia Diabetic Market Growth Drivers and
  • Key sustainability strategies adopted by market

Australia Diabetes Market
Australia Diabetes Market
Australia Diabetes Market
Contact Us
Australia Diabetes Market
Write a Comment
User Comments (0)